UniProtKB/Swiss-Prot Q99895: Variant p.Arg37Gln

Chymotrypsin-C
Gene: CTRC
Feedback?

Variant information Variant position:

37 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glutamine (Q) at position 37 (R37Q, p.Arg37Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Rare variant; results in normal secretion and activity. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs145868278 [ dbSNP | Ensembl ]

Sequence information Variant position:

37 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

268 The length of the canonical sequence.
Location on the sequence:

CGVPSFPPNLSARVVGGEDA R PHSWPWQISLQYLKNDTWRH The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CGVPSFPPNLSARVVGGEDARPHSWPWQISLQYLKNDTWRH

Mouse                         CGDPTFPPNLSARVVGGEDAVPNSWPWQVSLQYLRDDTWRH

Rat                           CGNPAFPPNLSTRVVGGEDAVPNSWPWQVSLQYLKDDTWRH

Bovine                        CGAPIFQPNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRH

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	30 – 268	Chymotrypsin-C
Domain	30 – 267	Peptidase S1
Glycosylation	25 – 25	N-linked (GlcNAc...) asparagine
Glycosylation	52 – 52	N-linked (GlcNAc...) asparagine
Disulfide bond	17 – 141

Literature citations
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.
Rosendahl J.; Witt H.; Szmola R.; Bhatia E.; Ozsvari B.; Landt O.; Schulz H.-U.; Gress T.M.; Pfuetzer R.; Loehr M.; Kovacs P.; Blueher M.; Stumvoll M.; Choudhuri G.; Hegyi P.; te Morsche R.H.M.; Drenth J.P.H.; Truninger K.; Macek M. Jr.; Puhl G.; Witt U.; Schmidt H.; Buening C.; Ockenga J.; Kage A.; Groneberg D.A.; Nickel R.; Berg T.; Wiedenmann B.; Boedeker H.; Keim V.; Moessner J.; Teich N.; Sahin-Toth M.;
Nat. Genet. 40:78-82(2008)
Cited for: VARIANTS PCTT THR-73; SER-217; ARG-217; ILE-235 AND TRP-254; VARIANTS HIS-35; ASN-35; GLN-37; ARG-48; GLU-172; SER-218; ARG-220; ALA-225; LEU-249 AND ASN-260; CHARACTERIZATION OF VARIANTS PCTT THR-73; SER-217; ILE-235 AND TRP-254; CHARACTERIZATION OF VARIANTS GLN-37 AND ARG-48;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.